MC
ABMD

Miles Capital’s Abiomed Inc ABMD Stock Holding History

Miles Capital’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-2,823
Closed -$309K – 214
2016
Q2 		$309K Buy
2,823
+156
+6% +$15.5K 0.21% 109
2016
Q1 		$253K Buy
+2,667
New +$225K 0.17% 144

Other funds holding ABMD

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
BlackRock Fund Advisors
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
BlackRock Institutional Trust
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
1832 Asset Management
1832 Asset Management Toronto, Ontario, Canada $199B AUM 37.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

Miles Capital's ABMD Position: Q3 2016 in Review

Miles Capital sold out of Abiomed Inc (ABMD) in Q3 2016, closing a stake of 2,823 shares — an estimated $309K sold.

Miles Capital first reported a position in ABMD in Q1 2016 and held it in 2 quarters. The position peaked at $309K in Q2 2016. 306 funds tracked by Wall St. Rank hold ABMD as of Q3 2016.

  • Miles Capital reported no remaining Abiomed Inc position as of Q3 2016 after selling out during the quarter.
  • Miles Capital sold 2,823 Abiomed Inc shares in Q3 2016, an estimated $309K.
  • Miles Capital first reported a position in Abiomed Inc in Q1 2016 and held it in 2 quarters.
  • Miles Capital's Abiomed Inc position peaked at $309K in Q2 2016.
  • 306 funds tracked by Wall St. Rank held Abiomed Inc as of Q3 2016.

Based on Miles Capital's 13F filing for Q3 2016, filed 15 Nov 2016.